ScreenerHero

ADXN Addex Therapeutics Ltd

NAS · US · Healthcare · Biotechnology · addextherapeutics.com
3.130USD-1.57%Mkt Cap: 5.49M $P/E: —

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enz…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap5.49M USD
Enterprise Value3.93M USD
Revenue (TTM)83.07K USD
Gross Profit-272.18K USD
Net Income (TTM)-6.73M USD
Revenue/Share0.12 USD
Last Price3.130 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-63.60
PEG—
EV/EBITDA-1.51
EV/Revenue47.35
P/S67.09
P/B2.01
EPS (TTM)-7.56
EPS (Forward)-0.05
52W Range
2.5606% of range11.97
52W High11.97 USD
52W Low2.560 USD
Profitability
Gross Margin0.00%
Oper. Margin-6487.25%
EBITDA Margin0.00%
Profit Margin-22448.44%
ROE-141.15%
ROA-105.72%
Growth
Revenue Growth-72.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.17M USD
CapEx (TTM)—
FCF Margin-1726.17%
FCF Yield-26.14%
Net Debt-689.83K USD
Net Debt/EBITDA0.26
Balance Sheet
Debt/Equity0.01
Current Ratio0.76
Quick Ratio0.58
Book Value/Sh1.58 USD
Cash/Share0.53 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateOct 23, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.75M
Float1.18M
Insiders0.00%
Institutions0.01%
Short Interest
Short Ratio0.0d
Short % Float0.02%
Short % Out.0.02%
Shares Short267
Short (prev mo.)7.08K
Technical
SMA 504.352 (-28.1%)
SMA 2006.281 (-50.2%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)284.76K
Avg Vol (10d)19.29K
Technical Indicators
RSI (14)38.8
MACD-0.3827
MACD Signal-0.4477
MACD Hist.+0.0649
BB Upper3.857 USD
BB Middle3.295 USD
BB Lower2.733 USD
BB Width34.11%
ATR (14)0.2958 USD
Vol Ratio (20d)0.36x